Northern Trust
CTOR

Northern Trust’s Citius Oncology CTOR Stock Holding History

Northern Trust’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.4K Hold
45,746
– – ﹤0.01% 4311
2025
Q4 		$45.7K Buy
45,746
+23,982
+110% +$34.4K ﹤0.01% 4296
2025
Q3 		$44.2K Buy
+21,764
New +$47.1K ﹤0.01% 4295

Other funds holding CTOR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Northern Trust's CTOR Position: Q1 2026 in Review

Northern Trust held its Citius Oncology (CTOR) position steady in Q1 2026 at 45,746 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4311.

Northern Trust first reported a position in CTOR in Q3 2025 and has held it in 3 quarters since. The position peaked at $45.7K in Q4 2025. 14 funds tracked by Wall St. Rank hold CTOR as of Q1 2026.

  • Northern Trust held 45,746 shares of Citius Oncology worth $28.4K as of Q1 2026.
  • Northern Trust left its Citius Oncology share count unchanged in Q1 2026.
  • Citius Oncology made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4311 holding.
  • Northern Trust first reported a position in Citius Oncology in Q3 2025 and has held it in 3 quarters since.
  • Northern Trust's Citius Oncology position peaked at $45.7K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Citius Oncology as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.